Beta human chorionic gonadotropin (b-HCG)
Ingredients Contaminants Sterilisation

[2014] UPDATED: Did the Kenyan Bishops Just Expose WHO & UNICEF?  we shall not waver in calling upon all Kenyans to avoid the tetanus vaccination campaign laced with Beta-HCG, because we are convinced that  it is indeed a disguised population control programme....Giving five doses of tetanus vaccination every 6 months is not usual or the recommended regime for tetanus vaccination. The only time tetanus vaccine has been given in five doses is when it is used as a carrier in fertility regulating vaccines laced with the pregnancy hormone – Human Chorionic Gonadotropin (HCG) developed by WHO in 1992.  When tetanus is laced with HCG and administered in five doses every 6 months, the woman develops antibodies against both the tetanus and the HCG in 2 – 3 years after the last injection. Once a mother develops antibodies against HCG, she rejects any pregnancy as soon as it starts growing in her womb thus causing repeated abortions and subsequent sterility.

[2014 March] Tetanus Vaccines Sterilizing Women In Kenya?  "Information in the public domain indicates that Tetanus Toxoid vaccine (TT) laced with Beta human chorionic gonadotropin (b-HCG) sub unit has been used in Philippines, Nicaragua and Mexico to vaccinate women against future pregnancy. Beta HCG sub unit is a hormone necessary for pregnancy"

[2012] Rockefeller Anti-Fertility Vaccines Exposed  Population Fund. Its mission, according to one of its members, to support: “basic and clinical research on the development of birth control vaccines directed against the gametes or the preimplantation embryo. These studies have involved the use of advanced procedures in peptide chemistry, hybridoma technology and molecular genetics as well as the evaluation of a number of novel approaches in general vaccinology. As a result of this international, collaborative effort, a prototype anti-HCG vaccine is now undergoing clinical testing, raising the prospect that a totally new family planning method may be available before the end of the current decade.” In regards to the scope of the Task Force’s jurisdiction, the Biotechnology and Development Monitor reported: “The Task Force acts as a global coordinating body for anti-fertility vaccine R&D in the various working groups and supports research on different approaches, such as anti-sperm and anti-ovum vaccines and vaccines designed to neutralize the biological functions of hCG. The Task Force has succeeded in developing a prototype of an anti-hCG-vaccine.”